0001567619-22-022021.txt : 20221227 0001567619-22-022021.hdr.sgml : 20221227 20221227120350 ACCESSION NUMBER: 0001567619-22-022021 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221227 DATE AS OF CHANGE: 20221227 EFFECTIVENESS DATE: 20221227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Xanadu Bio, Inc. CENTRAL INDEX KEY: 0001946059 IRS NUMBER: 870955170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-468749 FILM NUMBER: 221487560 BUSINESS ADDRESS: STREET 1: 980 IDLEWILD ROAD CITY: GLADWYNE STATE: PA ZIP: 19035 BUSINESS PHONE: 610-937-6000 MAIL ADDRESS: STREET 1: 980 IDLEWILD ROAD CITY: GLADWYNE STATE: PA ZIP: 19035 D 1 primary_doc.xml X0708 D LIVE 0001946059 Xanadu Bio, Inc. 980 IDLEWILD ROAD GLADWYNE PA PENNSYLVANIA 19035 610-937-6000 DELAWARE None None Corporation true 2021 Bruce Turner c/o Xanadu Bio, Inc. 980 Idlewild Road Gladwyne PA PENNSYLVANIA 19035 Executive Officer Director Promoter Dr. Turner if the Chief Executive Officer, President, Treasurer and Secretary of the Issuer. Todd Wider c/o Xanadu Bio, Inc. 980 Idlewild Road Gladwyne PA PENNSYLVANIA 19035 Executive Officer Director Promoter Dr. Wider is the Chief Medical Officer of the Issuer. Mark Saltzman c/o Xanadu Bio, Inc. 980 Idlewild Road Gladwyne PA PENNSYLVANIA 19035 Director Biotechnology Decline to Disclose 06b false 2022-08-16 false true true true Series A Preferred Stock false 0 30000000 11999986 18000014 false 8 0 0 0 false Xanadu Bio, Inc. /s/ Bruce Turner Bruce Turner Chief Executive Officer & President of the Issuer 2022-12-27